Loading…
The Column Group (TCG) is a venture ecosystem that fuels life sciences innovation by investing in biotechnology companies from early technology platforms through later-stage programs. Over two decades, TCG has started and invested in 55 companies, generating $4.0 billion in returns and achieving 18 company exits.
AI named The Column Group from December 2025 to February 2026.